The Claim
Endothelin-1 impairs GLUT4 translocation induced by hyperosmotic stress by targeting a shared, PI3K-independent signaling pathway that is common to both insulin and non-insulin stimuli.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Endothelin-1 reduces the movement of GLUT4 transporters to the cell membrane during hyperosmotic stress by interfering with a signaling pathway that both insulin and non-insulin signals use, independent of PI3K.
See the scientific wording
Endothelin-1 impairs GLUT4 translocation triggered by hyperosmotic stress, demonstrating that its mechanism targets a shared, PI3K-independent pathway common to both insulin and non-insulin stimuli.
Endothelin-1 binds to a receptor on the cell surface and shuts down a critical lipid signal called PIP2, which is needed to organize the cell's inner skeleton near the membrane. Without this skeleton properly formed, glucose transporters cannot move to the surface to let glucose in, no matter if the signal comes from insulin or high salt stress.
What the research says
1 studyStudy: Endothelin‐1 impairs glucose transporter trafficking via a membrane‐based mechanism
Endothelin-1 blocks glucose uptake in cells whether the signal comes from insulin or from high salt stress, because it breaks a shared part of the cell’s machinery—like cutting a common wire that both signals use to move glucose transporters to the cell surface.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.